Form 8-K - Current report:
SEC Accession No. 0001140361-16-082904
Filing Date
2016-10-18
Accepted
2016-10-18 06:03:05
Documents
4
Period of Report
2016-10-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 EDGE THERAPEUTICS, INC. 8-K 10-17-2016 form8k.htm 8-K 28781
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 88321
3 EXHIBIT 99.1 ex99_1.htm EX-99.1 13486
4 image1.jpg GRAPHIC 6565
  Complete submission text file 0001140361-16-082904.txt   141016
Mailing Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922 800-208-3343
Edge Therapeutics, Inc. (Filer) CIK: 0001472091 (see all company filings)

EIN.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37568 | Film No.: 161939789
SIC: 2834 Pharmaceutical Preparations